Search Results - "Eden, Georgina"
-
1
No evidence of durable trained immunity after two doses of adenovirus-vectored or mRNA COVID-19 vaccines
Published in The Journal of clinical investigation (01-09-2023)Get full text
Journal Article -
2
Accelerating development of high-risk neuroblastoma patient-derived xenograft models for preclinical testing and personalised therapy
Published in British journal of cancer (01-03-2020)“…Background Predictive preclinical models play an important role in the assessment of new treatment strategies and as avatar models for personalised medicine;…”
Get full text
Journal Article -
3
Macrophage-Derived IL1β and TNFα Regulate Arginine Metabolism in Neuroblastoma
Published in Cancer research (Chicago, Ill.) (01-02-2019)“…Neuroblastoma is the most common childhood solid tumor, yet the prognosis for high-risk disease remains poor. We demonstrate here that arginase 2 (ARG2) drives…”
Get full text
Journal Article -
4
The composition of the gut microbiota following early-life antibiotic exposure affects host health and longevity in later life
Published in Cell reports (Cambridge) (24-08-2021)“…Studies investigating whether there is a causative link between the gut microbiota and lifespan have largely been restricted to invertebrates or to mice with a…”
Get full text
Journal Article -
5
Rhubarb extract partially improves mucosal integrity in chemotherapy-induced intestinal mucositis
Published in World journal of gastroenterology : WJG (07-10-2016)“…AIM To investigate the effects of orally gavaged aqueous rhubarb extract(RE) on 5-fluorouracil(5-FU)-induced intestinal mucositis in rats. METHODS Female Dark…”
Get full text
Journal Article -
6
Emu Oil Combined with Lyprinol™ Reduces Small Intestinal Damage in a Rat Model of Chemotherapy-Induced Mucositis
Published in Nutrition and cancer (02-10-2016)“…Chemotherapy-induced mucositis is characterized by inflammation and ulcerating lesions lining the alimentary tract. Emu Oil and Lyprinol™ have independently…”
Get full text
Journal Article -
7
Suppression of the ATP-binding cassette transporter ABCC4 impairs neuroblastoma tumour growth and sensitises to irinotecan in vivo
Published in European journal of cancer (1990) (01-09-2017)“…The ATP-binding cassette transporter ABCC4 (multidrug resistance protein 4, MRP4) mRNA level is a strong predictor of poor clinical outcome in neuroblastoma…”
Get full text
Journal Article -
8
A systems immunology study comparing innate and adaptive immune responses in adults to COVID-19 mRNA and adenovirus vectored vaccines
Published in Cell reports. Medicine (21-03-2023)“…Identifying the molecular mechanisms that promote optimal immune responses to coronavirus disease 2019 (COVID-19) vaccination is critical for future rational…”
Get full text
Journal Article -
9
The immunotoxicity, but not anti-tumor efficacy, of anti-CD40 and anti-CD137 immunotherapies is dependent on the gut microbiota
Published in Cell reports. Medicine (21-12-2021)“…Immune agonist antibodies (IAAs) are promising immunotherapies that target co-stimulatory receptors to induce potent anti-tumor immune responses, particularly…”
Get full text
Journal Article -
10
No evidence of durable trained immunity after two doses of adenovirus-vectored or mRNA COVID-19 vaccines
Published in The Journal of clinical investigation (01-09-2023)Get full text
Journal Article -
11
Inhibition of polyamine synthesis and uptake reduces tumor progression and prolongs survival in mouse models of neuroblastoma
Published in Science translational medicine (30-01-2019)“…Amplification of the oncogene is associated with an aggressive phenotype and poor outcome in childhood neuroblastoma. Polyamines are highly regulated essential…”
Get more information
Journal Article -
12
Targeting metabolic activity in high-risk neuroblastoma through Monocarboxylate Transporter 1 (MCT1) inhibition
Published in Oncogene (23-04-2020)“…Amplification of the MYCN oncogene occurs in ~25% of primary neuroblastomas and is the single most powerful biological marker of poor prognosis in this…”
Get full text
Journal Article -
13
Abstract A35: P-Glycoprotein is a resistance mechanism for conventional induction chemotherapy but not ALK inhibitors in high-risk neuroblastoma
Published in Cancer research (Chicago, Ill.) (15-07-2020)“…Abstract Background: Despite intensive treatment, patients with high-risk neuroblastoma (HR-NB) have a five-year survival rate of only 50%, largely due to…”
Get full text
Journal Article -
14
Dual Targeting of Chromatin Stability By The Curaxin CBL0137 and Histone Deacetylase Inhibitor Panobinostat Shows Significant Preclinical Efficacy in Neuroblastoma
Published in Clinical cancer research (01-08-2021)“…We investigated whether targeting chromatin stability through a combination of the curaxin CBL0137 with the histone deacetylase (HDAC) inhibitor, panobinostat,…”
Get full text
Journal Article -
15
The transcriptional co-repressor Runx1t1 is essential for MYCN-driven neuroblastoma tumorigenesis
Published in Nature communications (11-07-2024)“…MYCN oncogene amplification is frequently observed in aggressive childhood neuroblastoma. Using an unbiased large-scale mutagenesis screen in…”
Get full text
Journal Article -
16
Abstract 4741: Re-evaluating the role of P-glycoprotein in the resistance of high-risk neuroblastoma to standard-of-care chemotherapies
Published in Cancer research (Chicago, Ill.) (01-07-2019)“…Abstract Background: Neuroblastoma is the most common extracranial solid malignancy in children, comprising 15% of cancer related deaths. Despite intensive…”
Get full text
Journal Article -
17
Abstract 2884: Establishment of patient-derived xenograft models for high-risk neuroblastoma
Published in Cancer research (Chicago, Ill.) (01-07-2019)“…Abstract Background: High-risk neuroblastoma (HR-NB) accounts for 15% of all pediatric oncology deaths, with long-term survival approximately 50%. Predictive…”
Get full text
Journal Article -
18
Abstract 2006: AMX-513 polyamine depletion therapy inhibits tumor growth and reverses immunosuppression in cancers including MYC-driven neuroblastoma and pancreatic cancer
Published in Cancer research (Chicago, Ill.) (01-07-2017)“…Abstract Tumorigenesis is associated with increased polyamine levels and involves the induction of ornithine decarboxylase (ODC), the initial rate-limiting…”
Get full text
Journal Article -
19
In vitro and in vivo drug screens of tumor cells identify novel therapies for high‐risk child cancer
Published in EMBO molecular medicine (07-04-2022)“…Biomarkers which better match anticancer drugs with cancer driver genes hold the promise of improved clinical responses and cure rates. We developed a…”
Get full text
Journal Article -
20
Macrophage-derived IL-1β and TNF-α regulate arginine metabolism in neuroblastoma
Published in Cancer research (Chicago, Ill.) (13-12-2018)“…Neuroblastoma is the most common childhood solid tumor, yet the prognosis for high-risk disease remains poor. We demonstrate here that arginase 2 (ARG2) drives…”
Get full text
Journal Article